NCT00272350View on ClinicalTrials.gov

ZD6474 to Treat Advanced Brain Cancer in Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

December 29, 2005

Primary Completion Date

February 27, 2014

Study Completion Date

February 27, 2014

Conditions
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
Interventions
DRUG

Steroids

DRUG

ZD6474

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00272350 - ZD6474 to Treat Advanced Brain Cancer in Patients | Biotech Hunter | Biotech Hunter